Report Summary
DNA Probe-based Diagnostic-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on DNA Probe-based Diagnostic industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of DNA Probe-based Diagnostic 2013-2017, and development forecast 2018-2023
Main market players of DNA Probe-based Diagnostic in EMEA, with company and product introduction, position in the DNA Probe-based Diagnostic market
Market status and development trend of DNA Probe-based Diagnostic by types and applications
Cost and profit status of DNA Probe-based Diagnostic, and marketing status
Market growth drivers and challenges
The report segments the EMEA DNA Probe-based Diagnostic market as:
EMEA DNA Probe-based Diagnostic Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA DNA Probe-based Diagnostic Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Probes-Based Products
Direct Detection of Target Sequence
Nucleic Acid Amplification
Gene Detection Using DNA Chips
Gene Detection by DNA Sequencing
EMEA DNA Probe-based Diagnostic Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Infectious disease testing
Cancer testing
EMEA DNA Probe-based Diagnostic Market: Players Segment Analysis (Company and Product introduction, DNA Probe-based Diagnostic Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
F. Hoffmann La Roche
GE Healthcare
Thermo Fisher Scientific
BD
Biogenex
bioMerieux
Biolegio
Luminex
MP Biomedicals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Interested in this report?
Get your sample now!
Table of Contents
Chapter 1 Overview of DNA Probe-based Diagnostic
1.1 Definition of DNA Probe-based Diagnostic in This Report
1.2 Commercial Types of DNA Probe-based Diagnostic
1.2.1 DNA Probes-Based Products
1.2.2 Direct Detection of Target Sequence
1.2.3 Nucleic Acid Amplification
1.2.4 Gene Detection Using DNA Chips
1.2.5 Gene Detection by DNA Sequencing
1.3 Downstream Application of DNA Probe-based Diagnostic
1.3.1 Infectious disease testing
1.3.2 Cancer testing
1.4 Development History of DNA Probe-based Diagnostic
1.5 Market Status and Trend of DNA Probe-based Diagnostic 2013-2023
1.5.1 EMEA DNA Probe-based Diagnostic Market Status and Trend 2013-2023
1.5.2 Regional DNA Probe-based Diagnostic Market Status and Trend 2013-2023
Chapter 2 EMEA Market Status and Forecast by Regions
2.1 Market Status of DNA Probe-based Diagnostic in EMEA 2013-2017
2.2 Consumption Market of DNA Probe-based Diagnostic in EMEA by Regions
2.2.1 Consumption Volume of DNA Probe-based Diagnostic in EMEA by Regions
2.2.2 Revenue of DNA Probe-based Diagnostic in EMEA by Regions
2.3 Market Analysis of DNA Probe-based Diagnostic in EMEA by Regions
2.3.1 Market Analysis of DNA Probe-based Diagnostic in Europe 2013-2017
2.3.2 Market Analysis of DNA Probe-based Diagnostic in Middle East 2013-2017
2.3.3 Market Analysis of DNA Probe-based Diagnostic in Africa 2013-2017
2.4 Market Development Forecast of DNA Probe-based Diagnostic in EMEA 2018-2023
2.4.1 Market Development Forecast of DNA Probe-based Diagnostic in EMEA 2018-2023
2.4.2 Market Development Forecast of DNA Probe-based Diagnostic by Regions 2018-2023
Chapter 3 EMEA Market Status and Forecast by Types
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of DNA Probe-based Diagnostic in EMEA by Types
3.1.2 Revenue of DNA Probe-based Diagnostic in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of DNA Probe-based Diagnostic in EMEA by Types
Chapter 4 EMEA Market Status and Forecast by Downstream Industry
4.1 Demand Volume of DNA Probe-based Diagnostic in EMEA by Downstream Industry
4.2 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Major Countries
4.2.1 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Europe
4.2.2 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Middle East
4.2.3 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Africa
4.3 Market Forecast of DNA Probe-based Diagnostic in EMEA by Downstream Industry
Chapter 5 Market Driving Factor Analysis of DNA Probe-based Diagnostic
5.1 EMEA Economy Situation and Trend Overview
5.2 DNA Probe-based Diagnostic Downstream Industry Situation and Trend Overview
Chapter 6 DNA Probe-based Diagnostic Market Competition Status by Major Players in EMEA
6.1 Sales Volume of DNA Probe-based Diagnostic in EMEA by Major Players
6.2 Revenue of DNA Probe-based Diagnostic in EMEA by Major Players
6.3 Basic Information of DNA Probe-based Diagnostic by Major Players
6.3.1 Headquarters Location and Established Time of DNA Probe-based Diagnostic Major Players
6.3.2 Employees and Revenue Level of DNA Probe-based Diagnostic Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 DNA Probe-based Diagnostic Major Manufacturers Introduction and Market Data
7.1 Abbott Laboratories
7.1.1 Company profile
7.1.2 Representative DNA Probe-based Diagnostic Product
7.1.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.2 F. Hoffmann La Roche
7.2.1 Company profile
7.2.2 Representative DNA Probe-based Diagnostic Product
7.2.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of F. Hoffmann La Roche
7.3 GE Healthcare
7.3.1 Company profile
7.3.2 Representative DNA Probe-based Diagnostic Product
7.3.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of GE Healthcare
7.4 Thermo Fisher Scientific
7.4.1 Company profile
7.4.2 Representative DNA Probe-based Diagnostic Product
7.4.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.5 BD
7.5.1 Company profile
7.5.2 Representative DNA Probe-based Diagnostic Product
7.5.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of BD
7.6 Biogenex
7.6.1 Company profile
7.6.2 Representative DNA Probe-based Diagnostic Product
7.6.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Biogenex
7.7 bioMerieux
7.7.1 Company profile
7.7.2 Representative DNA Probe-based Diagnostic Product
7.7.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of bioMerieux
7.8 Biolegio
7.8.1 Company profile
7.8.2 Representative DNA Probe-based Diagnostic Product
7.8.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Biolegio
7.9 Luminex
7.9.1 Company profile
7.9.2 Representative DNA Probe-based Diagnostic Product
7.9.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Luminex
7.10 MP Biomedicals
7.10.1 Company profile
7.10.2 Representative DNA Probe-based Diagnostic Product
7.10.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of MP Biomedicals
Chapter 8 Upstream and Downstream Market Analysis of DNA Probe-based Diagnostic
8.1 Industry Chain of DNA Probe-based Diagnostic
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of DNA Probe-based Diagnostic
9.1 Cost Structure Analysis of DNA Probe-based Diagnostic
9.2 Raw Materials Cost Analysis of DNA Probe-based Diagnostic
9.3 Labor Cost Analysis of DNA Probe-based Diagnostic
9.4 Manufacturing Expenses Analysis of DNA Probe-based Diagnostic
Chapter 10 Marketing Status Analysis of DNA Probe-based Diagnostic
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
List of Tables
Table Advantage and Disadvantage of DNA Probes-Based Products
Table Advantage and Disadvantage of Direct Detection of Target Sequence
Table Advantage and Disadvantage of Nucleic Acid Amplification
Table Advantage and Disadvantage of Gene Detection Using DNA Chips
Table Advantage and Disadvantage of Gene Detection by DNA Sequencing
Table Consumption Volume of DNA Probe-based Diagnostic in EMEA by Regions 2013-2017
Table Revenue of DNA Probe-based Diagnostic in EMEA by Regions 2013-2017
Table Consumption Volume of DNA Probe-based Diagnostic in EMEA by Regions 2018-2023
Table Revenue of DNA Probe-based Diagnostic in EMEA by Regions 2018-2023
Table Consumption Volume of DNA Probe-based Diagnostic in EMEA by Types 2013-2017
Table Revenue of DNA Probe-based Diagnostic in EMEA by Types 2013-2017
Table Consumption Volume of DNA Probe-based Diagnostic by Types in Europe 2013-2017
Table Consumption Volume of DNA Probe-based Diagnostic by Types in Middle East 2013-2017
Table Consumption Volume of DNA Probe-based Diagnostic by Types in Africa 2013-2017
Table Consumption Volume Forecast of DNA Probe-based Diagnostic in EMEA by Types 2018-2023
Table Revenue Forecast of DNA Probe-based Diagnostic in EMEA by Types 2018-2023
Table Demand Volume of DNA Probe-based Diagnostic in EMEA by Downstream Industry 2013-2017
Table Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Europe 2013-2017
Table Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Middle East 2013-2017
Table Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Africa 2013-2017
Table Demand Volume Forecast of DNA Probe-based Diagnostic in EMEA by Downstream Industry 2018-2023
Table Sales Volume of DNA Probe-based Diagnostic in EMEA by Major Players 2013-2017
Table Revenue of DNA Probe-based Diagnostic in EMEA by Major Players 2013-2017
Table Headquarters Location and Established Time of DNA Probe-based Diagnostic Major Players
Table Employees and Revenue Level of DNA Probe-based Diagnostic Major Players
Table Representative DNA Probe-based Diagnostic Product One of Abbott Laboratories
Table Representative DNA Probe-based Diagnostic Product Two of Abbott Laboratories
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2013-2017
Table Representative DNA Probe-based Diagnostic Product One of F. Hoffmann La Roche
Table Representative DNA Probe-based Diagnostic Product Two of F. Hoffmann La Roche
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of F. Hoffmann La Roche 2013-2017
Table Representative DNA Probe-based Diagnostic Product One of GE Healthcare
Table Representative DNA Probe-based Diagnostic Product Two of GE Healthcare
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of GE Healthcare 2013-2017
Table Representative DNA Probe-based Diagnostic Product One of Thermo Fisher Scientific
Table Representative DNA Probe-based Diagnostic Product Two of Thermo Fisher Scientific
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific 2013-2017
Table Representative DNA Probe-based Diagnostic Product One of BD
Table Representative DNA Probe-based Diagnostic Product Two of BD
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of BD 2013-2017
Table Representative DNA Probe-based Diagnostic Product One of Biogenex
Table Representative DNA Probe-based Diagnostic Product Two of Biogenex
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Biogenex 2013-2017
Table Representative DNA Probe-based Diagnostic Product One of bioMerieux
Table Representative DNA Probe-based Diagnostic Product Two of bioMerieux
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of bioMerieux 2013-2017
Table Representative DNA Probe-based Diagnostic Product One of Biolegio
Table Representative DNA Probe-based Diagnostic Product Two of Biolegio
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Biolegio 2013-2017
Table Representative DNA Probe-based Diagnostic Product One of Luminex
Table Representative DNA Probe-based Diagnostic Product Two of Luminex
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Luminex 2013-2017
Table Representative DNA Probe-based Diagnostic Product One of MP Biomedicals
Table Representative DNA Probe-based Diagnostic Product Two of MP Biomedicals
Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of MP Biomedicals 2013-2017